Literature DB >> 24006512

Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture.

Jacqueline A Hawkins-Salsbury1, Archana R Parameswar, Xuntian Jiang, Paul H Schlesinger, Ernesto Bongarzone, Daniel S Ory, Alexei V Demchenko, Mark S Sands.   

Abstract

Globoid cell leukodystrophy (GLD) is a neurological disease caused by deficiency of the lysosomal enzyme galactosylceramidase (GALC). In the absence of GALC, the cytotoxic glycosphingolipid, psychosine (psy), accumulates in the nervous system. Psychosine accumulation preferentially affects oligodendrocytes, leading to progressive demyelination and infiltration of activated monocytes/macrophages into the CNS. GLD is characterized by motor defects, cognitive deficits, seizures, and death by 2-5 years of age. It has been hypothesized that psychosine accumulation, primarily within lipid rafts, results in the pathogenic cascade in GLD. However, the mechanism of psychosine toxicity has yet to be elucidated. Therefore, we synthesized the enantiomer of psychosine (ent-psy) to use as a probe to distinguish between protein-psy (stereo-specific enantioselective) or membrane-psy (stereo-insensitive nonenantioselective) interactions. The enantiomer of psychosine has equal or greater toxicity compared with psy, suggesting that psy exerts its toxicity through a nonenantioselective mechanism. Finally, in this study we demonstrate that psy and ent-psy localize to lipid rafts, perturb natural and artificial membrane integrity, and inhibit protein Kinase C translocation to the plasma membrane. Although other mechanisms may play a role in disease, these data strongly suggest that psy exerts its effects primarily through membrane perturbation rather than through specific protein-psy interactions.

Entities:  

Keywords:  Krabbe disease; enantiomer; membrane alteration

Mesh:

Substances:

Year:  2013        PMID: 24006512      PMCID: PMC3826678          DOI: 10.1194/jlr.M039610

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

1.  Axonopathy is a compounding factor in the pathogenesis of Krabbe disease.

Authors:  Ludovico Cantuti Castelvetri; Maria Irene Givogri; Hongling Zhu; Benjamin Smith; Aurora Lopez-Rosas; Xi Qiu; Richard van Breemen; Ernesto Roque Bongarzone
Journal:  Acta Neuropathol       Date:  2011-03-04       Impact factor: 17.088

Review 2.  Biophysical investigation on left ventricular myocytes in rats with experimentally induced diabetes.

Authors:  I Waczulíková; M Cagalinec; O Uličná; P Slezák; A Ziegelhöffer
Journal:  Physiol Res       Date:  2010       Impact factor: 1.881

Review 3.  Additional deficiency of psychosine galactosidase in globoid cell leukodystrophy: an implication to enzyme replacement therapy.

Authors:  T Miyatake; K Suzuki
Journal:  Birth Defects Orig Artic Ser       Date:  1973-03

4.  Pore formation in and enlargement of phospholipid liposomes by synthetic models of ceramides and sphingomyelin.

Authors:  Robert Pajewski; Natasha Djedovic; Egan Harder; Riccardo Ferdani; Paul H Schlesinger; George W Gokel
Journal:  Bioorg Med Chem       Date:  2005-01-03       Impact factor: 3.641

5.  Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.

Authors:  Benny Liu; Charina M Ramirez; Anna M Miller; Joyce J Repa; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-11-18       Impact factor: 5.922

6.  Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.

Authors:  Xiao-qi Wang; Qiu Yan; Ping Sun; Ji-Wei Liu; Linda Go; Shauntae M McDaniel; Amy S Paller
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

7.  Psychosine-induced alterations in peroxisomes of twitcher mouse liver.

Authors:  Miguel Agustin Contreras; Ehtishamul Haq; Takuhiro Uto; Inderjit Singh; Avtar Kaur Singh
Journal:  Arch Biochem Biophys       Date:  2008-06-24       Impact factor: 4.013

8.  Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture.

Authors:  Adam B White; Maria I Givogri; Aurora Lopez-Rosas; Hongmei Cao; Richard van Breemen; Gopal Thinakaran; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

9.  The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease.

Authors:  Shailendra Giri; Mushfiquddin Khan; Narender Nath; Inderjit Singh; Avtar K Singh
Journal:  J Neurochem       Date:  2008-02-04       Impact factor: 5.372

10.  Concise Synthesis of the Unnatural Sphingosine and Psychosine Enantiomer.

Authors:  Archana R Parameswar; Jacqueline A Hawkins; Laurel K Mydock; Mark S Sands; Alexei V Demchenko
Journal:  European J Org Chem       Date:  2010-06
View more
  28 in total

Review 1.  Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.

Authors:  Stefka Spassieva; Erhard Bieberich
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 2.  Treatment for Krabbe's disease: Finding the combination.

Authors:  Christina R Mikulka; Mark S Sands
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 3.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

4.  Fluid levity of the cell: Role of membrane lipid architecture in genetic sphingolipidoses.

Authors:  Ludovic D'Auria; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 5.  How membrane dysfunction influences neuronal survival pathways in sphingolipid storage disorders.

Authors:  Tuba Sural-Fehr; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

6.  Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery.

Authors:  Monika Kopečná; Miloslav Macháček; Eva Prchalová; Petr Štěpánek; Pavel Drašar; Martin Kotora; Kateřina Vávrová
Journal:  Pharm Res       Date:  2017-06-29       Impact factor: 4.200

7.  A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum.

Authors:  Rohini Sidhu; Christina R Mikulka; Hideji Fujiwara; Mark S Sands; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Biomed Chromatogr       Date:  2018-04-26       Impact factor: 1.902

8.  Measurement of psychosine in dried blood spots--a possible improvement to newborn screening programs for Krabbe disease.

Authors:  Coleman T Turgeon; Joseph J Orsini; Karen A Sanders; Mark J Magera; Thomas J Langan; Maria L Escolar; Patricia Duffner; Devin Oglesbee; Dimitar Gavrilov; Silvia Tortorelli; Piero Rinaldo; Kimiyo Raymond; Dietrich Matern
Journal:  J Inherit Metab Dis       Date:  2015-03-12       Impact factor: 4.982

9.  Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Authors:  Jameson J Ribbens; Ann B Moser; Walter C Hubbard; Ernesto R Bongarzone; Gustavo H B Maegawa
Journal:  Mol Genet Metab       Date:  2013-09-21       Impact factor: 4.797

10.  Lipid-Conjugated Rigidochromic Probe Discloses Membrane Alteration in Model Cells of Krabbe Disease.

Authors:  Gerardo Abbandonato; Barbara Storti; Ilaria Tonazzini; Martin Stöckl; Vinod Subramaniam; Costanza Montis; Riccardo Nifosì; Marco Cecchini; Giovanni Signore; Ranieri Bizzarri
Journal:  Biophys J       Date:  2018-12-25       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.